These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21738112)

  • 21. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL; Xue YL; Song HJ; Luo QY
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Technetium-99m tetrofosmin uptake in insular thyroid carcinoma. A comparison with iodine-131.
    Degirmenci B; Aydin A; Comlekci A; Ozdogan O; Bekis R
    Clin Nucl Med; 2003 May; 28(5):385-8. PubMed ID: 12702934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bisphosphonates as radionuclide carriers for imaging or systemic therapy.
    Palma E; Correia JD; Campello MP; Santos I
    Mol Biosyst; 2011 Nov; 7(11):2950-66. PubMed ID: 21879109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone-seeking radiopharmaceuticals as targeted agents of osteosarcoma: samarium-153-EDTMP and radium-223.
    Anderson PM; Subbiah V; Rohren E
    Adv Exp Med Biol; 2014; 804():291-304. PubMed ID: 24924181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uptake of bone-seekers is solely associated with mineralisation! A study with 99mTc-MDP, 153Sm-EDTMP and 18F-fluoride on osteoblasts.
    Toegel S; Hoffmann O; Wadsak W; Ettlinger D; Mien LK; Wiesner K; Nguemo J; Viernstein H; Kletter K; Dudczak R; Mitterhauser M
    Eur J Nucl Med Mol Imaging; 2006 Apr; 33(4):491-4. PubMed ID: 16416330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of chemotherapy on bony metastases as measured by quantitative skeletal imaging.
    DeLuca SA; Castronovo FP; Rhea JT
    Clin Nucl Med; 1983 Jan; 8(1):11-3. PubMed ID: 6831814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone metastases and lung cancer recurrence on (99m)Tc-depreotide imaging.
    Meristoudis G; Ilias I; Batsakis C; Christakopoulou J
    Hell J Nucl Med; 2008; 11(3):185-6, author reply 186. PubMed ID: 19081868
    [No Abstract]   [Full Text] [Related]  

  • 28. Radionuclide bone imaging: an illustrative review.
    Love C; Din AS; Tomas MB; Kalapparambath TP; Palestro CJ
    Radiographics; 2003; 23(2):341-58. PubMed ID: 12640151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of pre-treatment and follow-up skeletal scintigraphy in operable breast cancer.
    Pauwels EK; Heslinga JM; Zwaveling A
    Clin Oncol; 1982 Mar; 8(1):25-32. PubMed ID: 6280915
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
    Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
    J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radionuclide therapy and integrated protocols for bone metastases.
    Chiacchio S; Mazzarri S; Lorenzoni A; Nyakale N; Boni G; Borsò E; Alsharif A; Grosso M; Manca G; Greco C; Volterrani D; Mariani G
    Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):431-47. PubMed ID: 21738116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Bone-seeking radiopharmaceuticals in evaluating the treatment of skeletal metastases of malignant tumors].
    Naumenko AZ; Korsunskiĭ VN
    Med Radiol (Mosk); 1984 Mar; 29(3):27-30. PubMed ID: 6321881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extraosseous accumulation of Tc-99m diphosphonate.
    Hendel HW; Buhl T; Mortensen J; Toft LV; Hesse B
    Clin Nucl Med; 2000 Oct; 25(10):844-6. PubMed ID: 11043739
    [No Abstract]   [Full Text] [Related]  

  • 34. Current use and future potential of organometallic radiopharmaceuticals.
    Schibli R; Schubiger PA
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1529-42. PubMed ID: 12397472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastric accumulation of bone seeking agent in a patient with advanced gastric cancer.
    Kim DW; Jeong HJ; Park SA; Kim CG
    J Korean Med Sci; 2007 Feb; 22(1):153-5. PubMed ID: 17297271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone scintiscanning in osteolytic lesions.
    Solav S
    Clin Nucl Med; 2004 Jan; 29(1):12-20. PubMed ID: 14688592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma.
    Chakraborty D; Bhattacharya A; Mete UK; Mittal BR
    Clin Nucl Med; 2013 Aug; 38(8):616-21. PubMed ID: 23603596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Two cases of bone metastases from primary hepatoma].
    Kurooka N; Tokumoto Y; Itoh J; Bando H; Morimoto K; Matsumori S; Okauchi S; Shimazu H
    Rinsho Hoshasen; 1984 Jan; 29(1):131-4. PubMed ID: 6234411
    [No Abstract]   [Full Text] [Related]  

  • 39. 99mTc-sestamibi radio-guided surgery of loco-regional 131Iodine-negative recurrent thyroid cancer.
    Rubello D; Salvatori M; Casara D; Piotto A; Toniato A; Gross MD; Al-Nahhas A; Muzzio PC; Pelizzo MR
    Eur J Surg Oncol; 2007 Sep; 33(7):902-6. PubMed ID: 17267163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relative lesion detection ability of Tc-99m HMDP and Tc-99m MDP: concise communication.
    Van Duzee BF; Schaefer JA; Ball JD; Chilton HM; Cowan RJ; Kuni C; Trow R; Watson NE
    J Nucl Med; 1984 Feb; 25(2):166-9. PubMed ID: 6233404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.